Other relevant GI findings detected with endoscopic screening
Barrett’s esophagus, cancer, esophageal adenocarcinoma
RECURRENCE, ESOPHAGEAL ADENOCARCINOMA, CANCER, GASTRIC INTESTINAL METAPLASIA, GASTROESOPHAGEAL REFLUX DISEASE, GASTRIC CANCER

During endoscopic screening, one patient was diagnosed with an esophageal adenocarcinoma and one patient was diagnosed with gastric cancer. Both patients could be treated curatively with endoscopic resection (EMR n = 1, ESD n = 1), and histopathological assessment revealed T1a cancer (n = 2). Both patients received endoscopic follow-up without recurrence. The patient diagnosed with esophageal adenocarcinoma was also treated with radiofrequency ablation. Other findings included the presence of gastroesophageal reflux disease (13.4 %; grade A in 5.0 %, grade B in 5.9 %, grade C in 1.0 %, and grade D 0.5 %), Barrett’s esophagus (10.4 %), and gastric intestinal metaplasia or confirmed
